tag:blogger.com,1999:blog-10381465.post116917311245090030..comments2007-02-08T11:18:37.726-08:00Wesley J. Smithhttp://www.blogger.com/profile/00087063614354714652wjs@wesleyjsmith.comBlogger3125tag:blogger.com,1999:blog-10381465.post-1169221376100698832007-01-19T07:42:00.000-08:002007-01-19T07:42:00.000-08:00I am not sure what "assignee-after-issue" means (Wesley, you're the lawyer), but UMass is noted as such (and ACT the "assingee-at-issue) in a patent filed in 2003 that is described as follows: "Methods and cell lines for cloning ungulate embryos and offspring, in particular bovines and porcines, are provided. The resultant fetuses, embryos or offspring are especially useful for the expression of desired heterologous DNAs, and may be used as a source of cells or tissue for transplantation therapy for the treatment of diseases such as Parkinson's disease."<BR/><BR/>Whether UMass still holds the patent, I couldn't find.Gregory L. Fordhttp://www.blogger.com/profile/15614707701876833091noreply@blogger.comtag:blogger.com,1999:blog-10381465.post-1169218643693419982007-01-19T06:57:00.000-08:002007-01-19T06:57:00.000-08:00Unknown.Wesley J. Smithhttp://www.blogger.com/profile/00087063614354714652noreply@blogger.comtag:blogger.com,1999:blog-10381465.post-1169188409411060272007-01-18T22:33:00.000-08:002007-01-18T22:33:00.000-08:00Wesley, can you dig up the relationship between ACT and the University of Massahcustts? As I recall, the founders of ACT were all researchers at UMass Worcester before spinning off into a private company, and the state of Massachusetts actually owned the patent for somatic cell nuclear transfer for a little while, until it was contested by another state. Do we still own it, or not?John Howardhttp://www.blogger.com/profile/01355786688900107071noreply@blogger.com